Skip to main content
SpringerLink
Log in

Atypical protein kinase C in cell motility

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

Cell motility is defined as cell movement in the three-dimensional space leading to repositioning of the cell. Atypical protein kinase C (aPKC, including ζ and λ/ι) are a subfamily of PKC. Different from classic PKC and novel PKC, the activation of atypical PKC is not dependent on diacylglycerol or calcium. PKCζ can be activated by lipid components, such as phosphatidylinositols, phosphatidic acid, arachidonic acid, and ceramide. Both phosphatidylinositol (3,4,5)-trisphosphate and PDK1 are necessary for the complete and stable activation of PKCζ. Atypical PKC is involved in the regulation of cell polarization, directional sensing, formation of filopodia, and cell motility. It is essential for migration and invasion of multiple cancer cell types. Particularly, atypical PKC has been found in the regulation of the motility of hematopoietic cells. It also participates in the regulation of proteolytic activity of podosomes and invadopodia. It has been found that atypical PKC can work coordinately with other PKC subfamily members and other signaling pathways. Research on the roles of atypical PKC in cell motility may lead to new therapeutic strategies for cancer and other diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Newton AC (2003) Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370:361–371

    Article  PubMed  CAS  Google Scholar 

  2. Gonzalez-Guerrico AM, Meshki J, Xiao L, Benavides F, Conti CJ, Kazanietz MG (2005) Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J Biochem Mol Biol 38:639–645

    Article  PubMed  CAS  Google Scholar 

  3. Carter CA, Kane CJ (2004) Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr Med Chem 11:2883–2902

    Article  PubMed  CAS  Google Scholar 

  4. de Barry J, Liegeois CM, Janoshazi A (2010) Protein kinase C as a peripheral biomarker for Alzheimer’s disease. Exp Gerontol 45:64–69

    Article  PubMed  Google Scholar 

  5. Dempsey EC, Cool CD, Littler CM (2007) Lung disease and PKCs. Pharmacol Res 55:545–559

    Article  PubMed  CAS  Google Scholar 

  6. Harper MT, Poole AW (2010) Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 8:454–462

    Article  PubMed  CAS  Google Scholar 

  7. Gonelli A, Mischiati C, Guerrini R, Voltan R, Salvadori S, Zauli G (2009) Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini Rev Med Chem 9:498–509

    Article  PubMed  CAS  Google Scholar 

  8. Ali AS, Ali S, El-Rayes BF, Philip PA, Sarkar FH (2009) Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat Rev 35:1–8

    Article  PubMed  CAS  Google Scholar 

  9. Tuttle KR (2008) Protein kinase C-beta inhibition for diabetic kidney disease. Diabetes Res Clin Pract 82(Suppl 1):S70–S74

    Article  PubMed  CAS  Google Scholar 

  10. Galvez MI (2009) Rubosixtaurin and other PKC inhibitors in diabetic retinopathy and macular edema. Review. Curr Diabetes Rev 5:14–17

    Article  PubMed  CAS  Google Scholar 

  11. Lang D, Beermann ML, Hauser G, Cressman CM, Shea TB (1995) Phospholipids inhibit proteolysis of protein kinase C alpha by mM calcium-requiring calpain. Neurochem Res 20:1361–1364

    Article  PubMed  CAS  Google Scholar 

  12. Parker PJ, Murray-Rust J (2004) PKC at a glance. J Cell Sci 117:131–132

    Article  PubMed  CAS  Google Scholar 

  13. Griner EM, Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7:281–294

    Article  PubMed  CAS  Google Scholar 

  14. Vertommen D, Rider M, Ni Y, Waelkens E, Merlevede W, Vandenheede JR, Van Lint J (2000) Regulation of protein kinase D by multisite phosphorylation. Identification of phosphorylation sites by mass spectrometry and characterization by site-directed mutagenesis. J Biol Chem 275:19567–19576

    Article  PubMed  CAS  Google Scholar 

  15. Oliva JL, Griner EM, Kazanietz MG (2005) PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors. Growth Factors 23:245–252

    Article  PubMed  CAS  Google Scholar 

  16. Corbalan-Garcia S, Gomez-Fernandez JC (2006) Protein kinase C regulatory domains: the art of decoding many different signals in membranes. Biochim Biophys Acta Mol Cell Biol Lipids 1761:633–654

    Article  CAS  Google Scholar 

  17. Ono Y, Fujii T, Igarashi K, Kuno T, Tanaka C, Kikkawa U, Nishizuka Y (1989) Phorbol ester binding to protein kinase-C requires a cysteine-rich zinc-finger-like sequence. Proc Natl Acad Sci USA 86:4868–4871

    Article  PubMed  CAS  Google Scholar 

  18. Hurley JH, Newton AC, Parker PJ, Blumberg PM, Nishizuka Y (1997) Taxonomy and function of C1 protein kinase C homology domains. Protein Sci 6:477–480

    Article  PubMed  CAS  Google Scholar 

  19. Gomez-Fernandez JC, Torrecillas A, Corbalan-Garcia S (2004) Diacylglycerols as activators of protein kinase C (Review). Mol Membr Biol 21:339–349

    Article  PubMed  CAS  Google Scholar 

  20. Rizo J, Sudhof TC (1998) C-2-domains, structure and function of a universal Ca2+-binding domain. J Biol Chem 273:15879–15882

    Article  PubMed  CAS  Google Scholar 

  21. Nalefski EA, Falke JJ (1996) The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci 5:2375–2390

    Article  PubMed  CAS  Google Scholar 

  22. Colon-Gonzalez F, Kazanietz MG (2006) C1 domains exposed: from diacylglycerol binding to protein–protein interactions. Biochim Biophys Acta 1761:827–837

    Article  PubMed  CAS  Google Scholar 

  23. Keenan C, Kelleher D (1998) Protein kinase C and the cytoskeleton. Cell Signal 10:225–232

    Article  PubMed  CAS  Google Scholar 

  24. Newton AC (1997) Regulation of protein kinase C. Curr Opin Cell Biol 9:161–167

    Article  PubMed  CAS  Google Scholar 

  25. Hirai T, Chida K (2003) Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J Biochem (Tokyo) 133:1–7

    Article  CAS  Google Scholar 

  26. Ways DK, Cook PP, Webster C, Parker PJ (1992) Effect of phorbol esters on protein kinase-C-zeta. J Biol Chem 267:4799–4805

    PubMed  CAS  Google Scholar 

  27. Nakanishi H, Brewer KA, Exton JH (1993) Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 268:13–16

    PubMed  CAS  Google Scholar 

  28. Limatola C, Schaap D, Moolenaar WH, van Blitterswijk WJ (1994) Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. Biochem J 304(Pt 3):1001–1008

    PubMed  CAS  Google Scholar 

  29. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K (1995) PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14:1961–1969

    PubMed  CAS  Google Scholar 

  30. Takenawa T, Itoh T (2001) Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane. Biochim Biophys Acta 1533:190–206

    Article  PubMed  CAS  Google Scholar 

  31. Takenawa T, Itoh T (2006) Membrane targeting and remodeling through phosphoinositide-binding domains. IUBMB Life 58:296–303

    Article  PubMed  CAS  Google Scholar 

  32. Gusarova GA, Dada LA, Kelly AM, Brodie C, Witters LA, Chandel NS, Sznajder JI (2009) Alpha 1-AMP-activated protein kinase regulates hypoxia-induced Na, K-ATPase endocytosis via direct phosphorylation of PKC zeta. Mol Cell Biol 29:3455–3464

    Article  PubMed  CAS  Google Scholar 

  33. Kolsch V, Charest PG, Firtel RA (2008) The regulation of cell motility and chemotaxis by phospholipid signaling. J Cell Sci 121:551–559

    Article  PubMed  CAS  Google Scholar 

  34. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279:509–514

    Article  PubMed  CAS  Google Scholar 

  35. Etienne-Manneville S, Hall A (2001) Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106:489–498

    Article  PubMed  CAS  Google Scholar 

  36. Hung TJ, Kemphues KJ (1999) PAR-6 is a conserved PDZ domain-containing protein that colocalizes with PAR-3 in Caenorhabditis elegans embryos. Development 126:127–135

    PubMed  CAS  Google Scholar 

  37. Izumi Y, Hirose T, Tamai Y, Hirai S, Nagashima Y, Fujimoto T, Tabuse Y, Kemphues KJ, Ohno S (1998) An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol 143:95–106

    Article  PubMed  CAS  Google Scholar 

  38. Joberty G, Petersen C, Gao L, Macara IG (2000) The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2:531–539

    Article  PubMed  CAS  Google Scholar 

  39. Lin D, Edwards AS, Fawcett JP, Mbamalu G, Scott JD, Pawson T (2000) A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat Cell Biol 2:540–547

    Article  PubMed  CAS  Google Scholar 

  40. Qiu RG, Abo A, Steven Martin G (2000) A human homolog of the C. elegans polarity determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell transformation. Curr Biol 10:697–707

    Article  PubMed  CAS  Google Scholar 

  41. Luna-Ulloa LB, Hernandez-Maqueda JG, Castaneda-Patlan MC, Robles-Flores M (2011) Protein kinase C in Wnt signaling: implications in cancer initiation and progression. IUBMB Life 63:873–879

    Article  CAS  Google Scholar 

  42. Schlessinger K, McManus EJ, Hall A (2007) Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity. J Cell Biol 178:355–361

    Article  PubMed  CAS  Google Scholar 

  43. Ishida-Takagishi M, Enomoto A, Asai N, Ushida K, Watanabe T, Hashimoto T, Kato T, Weng L, Matsumoto S, Asai M, Murakumo Y, Kaibuchi K, Kikuchi A, Takahashi M (2012) The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility. Nat Commun 3:859

    Article  PubMed  Google Scholar 

  44. Luna-Ulloa LB, Hernandez-Maqueda JG, Santoyo-Ramos P, Castaneda-Patlan MC, Robles-Flores M (2011) Protein kinase C zeta is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines. Carcinogenesis 32:1615–1624

    Article  PubMed  CAS  Google Scholar 

  45. To C, Kulkarni S, Pawson T, Honda T, Gribble GW, Sporn MB, Wrana JL, Di Guglielmo GM (2008) The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor beta-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complex. J Biol Chem 283:11700–11713

    Article  PubMed  CAS  Google Scholar 

  46. Frederick LA, Matthews JA, Jamieson L, Justilien V, Thompson EA, Radisky DC, Fields AP (2008) Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene 27:4841–4853

    Article  PubMed  CAS  Google Scholar 

  47. Loitto VM, Huang C, Sigal YJ, Jacobson K (2007) Filopodia are induced by aquaporin-9 expression. Exp Cell Res 313:1295–1306

    Article  PubMed  CAS  Google Scholar 

  48. Laudanna C, Sorio C, Tecchio C, Butcher EC, Bonora A, Bassi C, Scarpa A (2003) Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement. Lab Invest 83:1155–1163

    Article  PubMed  CAS  Google Scholar 

  49. Palma-Nicolas JP, Lopez E, Lopez-Colome AM (2010) Thrombin stimulates RPE cell motility by PKC-zeta- and NF-kappaB-dependent gene expression of MCP-1 and CINC-1/GRO chemokines. J Cell Biochem 110:948–967

    Article  PubMed  CAS  Google Scholar 

  50. Kuribayashi K, Nakamura K, Tanaka M, Sato T, Kato J, Sasaki K, Takimoto R, Kogawa K, Terui T, Takayama T, Onuma T, Matsunaga T, Niitsu Y (2007) Essential role of protein kinase C zeta in transducing a motility signal induced by superoxide and a chemotactic peptide, fMLP. J Cell Biol 176:1049–1060

    Article  PubMed  CAS  Google Scholar 

  51. Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ, Zhang N (2005) Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res 65:1433–1441

    Article  PubMed  CAS  Google Scholar 

  52. Xiao A, Yin C, Yang C, Di Cristofano A, Pandolfi PP, Van Dyke T (2005) Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. Cancer Res 65:5172–5180

    Article  PubMed  CAS  Google Scholar 

  53. Powell CT, Fair WR, Heston WD (1994) Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors. Cell Growth Differ 5:143–149

    PubMed  CAS  Google Scholar 

  54. Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D, Huryk R (1996) Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Cancer Res 56:4137–4141

    PubMed  CAS  Google Scholar 

  55. Petit I, Goichberg P, Spiegel A, Peled A, Brodie C, Seger R, Nagler A, Alon R, Lapidot T (2005) Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. J Clin Invest 115:168–176

    PubMed  CAS  Google Scholar 

  56. Forde S, Tye BJ, Newey SE, Roubelakis M, Smythe J, McGuckin CP, Pettengell R, Watt SM (2007) Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells. Blood 109:1825–1833

    Article  PubMed  CAS  Google Scholar 

  57. Guo H, Ma Y, Zhang B, Sun B, Niu R, Ying G, Zhang N (2009) Pivotal advance: PKCzeta is required for migration of macrophages. J Leukoc Biol 85:911–918

    Article  PubMed  CAS  Google Scholar 

  58. Gorshkova I, He D, Berdyshev E, Usatuyk P, Burns M, Kalari S, Zhao Y, Pendyala S, Garcia JG, Pyne NJ, Brindley DN, Natarajan V (2008) Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1. J Biol Chem 283:11794–11806

    Article  PubMed  CAS  Google Scholar 

  59. Crean JK, Furlong F, Finlay D, Mitchell D, Murphy M, Conway B, Brady HR, Godson C, Martin F (2004) Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. FASEB J 18:1541–1543

    PubMed  CAS  Google Scholar 

  60. Furlong F, Crean J, Thornton L, O’Leary R, Murphy M, Martin F (2007) Dysregulated intracellular signaling impairs CTGF-stimulated responses in human mesangial cells exposed to high extracellular glucose. Am J Physiol Renal Physiol 292:F1691–F1700

    Article  PubMed  CAS  Google Scholar 

  61. Buccione R, Orth JD, McNiven MA (2004) Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 5:647–657

    Article  PubMed  CAS  Google Scholar 

  62. Linder S, Aepfelbacher M (2003) Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 13:376–385

    Article  PubMed  CAS  Google Scholar 

  63. Linder S (2007) The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 17:107–117

    Article  PubMed  CAS  Google Scholar 

  64. Collin O, Na S, Chowdhury F, Hong M, Shin ME, Wang F, Wang N (2008) Self-organized podosomes are dynamic mechanosensors. Curr Biol 18:1288–1294

    Article  PubMed  CAS  Google Scholar 

  65. Stylli SS, Kaye AH, Lock P (2008) Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci 15:725–737

    Article  PubMed  CAS  Google Scholar 

  66. Mueller SC, Chen WT (1991) Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. J Cell Sci 99(Pt 2):213–225

    PubMed  CAS  Google Scholar 

  67. Baldassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA, Luini A, Buccione R (2003) Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell 14:1074–1084

    Article  PubMed  CAS  Google Scholar 

  68. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66:3034–3043

    Article  PubMed  CAS  Google Scholar 

  69. Xiao H, Li DX, Liu M (2012) Knowledge translation: airway epithelial cell migration and respiratory diseases. Cell Mol Life Sci. doi:10.1007/s00018-012-1044-z

    Google Scholar 

  70. Xiao H, Eves R, Yeh C, Kan W, Xu F, Mak AS, Liu M (2009) Phorbol ester-induced podosomes in normal human bronchial epithelial cells. J Cell Physiol 218:366–375

    Article  PubMed  CAS  Google Scholar 

  71. Xiao H, Bai XH, Kapus A, Lu WY, Mak AS, Liu M (2010) The protein kinase C cascade regulates recruitment of matrix metalloprotease 9 to podosomes and its release and activation. Mol Cell Biol 30:5545–5561

    Article  PubMed  CAS  Google Scholar 

  72. Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC (2004) Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. Mol Cell Biol 24:7578–7597

    Article  PubMed  CAS  Google Scholar 

  73. Walker VG, Ammer A, Cao Z, Clump AC, Jiang BH, Kelley LC, Weed SA, Zot H, Flynn DC (2007) PI3 K activation is required for PMA-directed activation of cSrc by AFAP-110. Am J Physiol Cell Physiol 293:C119–C132

    Article  PubMed  CAS  Google Scholar 

  74. Dorfleutner A, Cho Y, Vincent D, Cunnick J, Lin H, Weed SA, Stehlik C, Flynn DC (2008) Phosphorylation of AFAP-110 affects podosome lifespan in A7r5 cells. J Cell Sci 121:2394–2405

    Article  PubMed  CAS  Google Scholar 

  75. Xiao H, Han B, Lodyga M, Bai XH, Wang Y, Liu M (2012) The actin-binding domain of actin filament-associated protein (AFAP) is involved in the regulation of cytoskeletal structure. Cell Mol Life Sci 69:1137–1151

    Article  PubMed  CAS  Google Scholar 

  76. Xiao H, Bai X-H, Wang Y, Kim H, Mak AS, Liu M (2012) MEK/ERK pathway mediates PKC activation-induced recruitment of PKC zeta and MMP-9 to podosomes. J Cell Physiol. doi:10.1002/jcp.24146

    Google Scholar 

  77. Rodriguez EM, Dunham EE, Martin GS (2009) Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells. J Cell Physiol 221:171–182

    Article  PubMed  CAS  Google Scholar 

  78. Urtreger AJ, Grossoni VC, Falbo KB, Kazanietz MG, Bal de Kier Joffe EM (2005) Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells. Mol Carcinog 42:29–39

    Article  PubMed  CAS  Google Scholar 

  79. Esteve PO, Chicoine E, Robledo O, Aoudjit F, Descoteaux A, Potworowski EF, St-Pierre Y (2002) Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem 277:35150–35155

    Article  PubMed  CAS  Google Scholar 

  80. Huang HC, Huang CY, Lin-Shiau SY, Lin JK (2009) Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol Carcinog 48:517–531

    Article  PubMed  CAS  Google Scholar 

  81. Roffey J, Rosse C, Linch M, Hibbert A, McDonald NQ, Parker PJ (2009) Protein kinase C intervention: the state of play. Curr Opin Cell Biol 21:268–279

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Canadian Institutes of Health Research (CIHR) operating Grants MOP-13270, MOP-42546 and MOP-119514 to M.L. H.X. was a recipient of the Peterborough K.M. Hunter Graduate Studentship for Cancer Research.

Author information

Authors and Affiliations

  1. Latner Thoracic Surgery Research Laboratories, Toronto General Research Institute, University Health Network, Toronto, ON, Canada

    Helan Xiao & Mingyao Liu

  2. Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada

    Helan Xiao & Mingyao Liu

  3. Department of Surgery and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada

    Mingyao Liu

  4. Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada

    Mingyao Liu

  5. Faculty of Medicine, University of Toronto, Toronto General Hospital, Room TMDT 2-814, 101 College Street, Toronto, ON, M5G 1L7, Canada

    Mingyao Liu

Authors
  1. Helan Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mingyao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mingyao Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao, H., Liu, M. Atypical protein kinase C in cell motility. Cell. Mol. Life Sci. 70, 3057–3066 (2013). https://doi.org/10.1007/s00018-012-1192-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-012-1192-1

Keywords

Search

Navigation